CAPSTANTX

Serial Number 98850043
665

Registration Progress

Application Filed
Nov 12, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

CAPSTANTX

Basic Information

Serial Number
98850043
Filing Date
November 12, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
665
Status Date
Dec 5, 2025
Application
Pending
Classes
005

Rights Holder

CAPSTAN THERAPEUTICS, INC.

03
Address
1 N. Waukegan Road
North Chicago, IL 60064

Ownership History

CAPSTAN THERAPEUTICS, INC.

Original Applicant
03
North Chicago, IL

Legal Representation

Attorney
Joi A. White

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description Documents
Dec 5, 2025 NAUD R REPORT UNRESPONSIVE AMENDMENT - COMPLETED Loading...
Nov 6, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Nov 6, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 6, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 6, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 6, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 6, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 7, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 7, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 7, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 20, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Aug 20, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 22, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 22, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 22, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 8, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 6, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 6, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals; pharmaceutical preparations; pharmaceutical substances; therapeutics; therapeutic agents; biopharmaceuticals; medicines; drugs; vaccines; in vivo cell therapies; cells for medical or clinical use; stem cells for medical purposes; cells for medical use; genetically engineered cells; systems to express therapeutic proteins in vivo; gene therapy products; gene therapy preparations; gene therapy products, namely, genetically engineered cells for transplant purposes; in vivo nucleic acid, DNA, RNA, and mRNA technologies; targeted in vivo RNA technologies; lipid nanoparticles for medicinal use; binding moiety decorated lipid nanoparticles for medicinal use; lipid nanoparticles for durable cell reprogramming or cell engineering; binding moiety decorated lipid nanoparticles for durable cell reprogramming or cell engineering; targeted lipid nanoparticles for medicinal use; targeted lipid nanoparticles for durable cell reprogramming or cell engineering; targeted lipid nanoparticles for transient cell reprogramming or cell engineering; cell engineering platforms; cell engineering platforms for treatment of human diseases, disorders and conditions; technology platforms for developing and engineering therapeutic cells; in vivo cell engineering platforms; transient in vivo cell engineering platforms for durable gene therapy; technology platforms for transfection, namely, binding moiety decorated lipid nanoparticles for genetic engineering; reagents for transfection; reagents for transfection in vivo; reagents for transfection, namely, binding moiety decorated lipid nanoparticles; technology platforms for delivery of a payload by binding moiety decorated lipid nanoparticles including antibody decorated lipid nanoparticles; technology platforms for delivery of a nucleic acid payload; technology platforms for delivery of a negatively charged payload; biologics delivery systems; biologics delivery platforms; reagents for delivery of a payload by binding moiety decorated lipid nanoparticles including antibody decorated lipid nanoparticles; cell engineering platforms consisting of reagents, lipid nanoparticles, cell receptors, proteins, recombinant protein binders, mRNA, and antibodies or antigen binding portions thereof; biological technology platforms consisting of reagents, lipid nanoparticles, cell receptors, proteins, recombinant protein binders, nucleic acid, DNA, RNA, mRNA, and antibodies or antigen binding portions thereof, for the treatment and prevention of treatment of human diseases, disorders and conditions; chemical reagents for medical uses; clinical medical reagents; reagents for medical use; biological reagents for medical use; binding moiety decorated lipid nanoparticles

Additional Information

Design Mark
The mark consists of a curving unbroken line that crosses over itself suggesting a stylized letter "c" adjacent to the word "capstantx".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005